Product
Help
Pricing
About
Jobs
Log in
Get started
Institution
Add to collection
Shanghai Zhimeng Biopharma, Inc. (China)
Homepage:
core-biopharma.com
Alternate names:
Shanghai Zhimeng Biopharma,
Shanghai Zhimeng Biopharma, Inc.,
Zhimeng Biopharma
ROR:
01763te91
OpenAlex ID:
I4405267096
Electrophysiological and pharmacological characterization of a novel and potent neuronal Kv7 channel opener SCR2682 for antiepilepsy
2019
·
Fan Zhang
, Yani Liu
, et al.
·
The FASEB Journal
·
38
Safety, tolerability, pharmacokinetics, and antiviral activity of the novel core protein allosteric modulator ZM-H1505R (Canocapavir) in chronic hepatitis B patients: a randomized multiple-dose escalation trial
2023
·
Haiyan Jia
, Jiajia Mai
, et al.
·
BMC Medicine
·
25
PDF
Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein
2023
·
Yuan Zheng
, Le Yang
, et al.
·
Viruses
·
14
PDF
Safety, Tolerability, and Pharmacokinetics of a Novel Human Hepatitis B Virus Capsid Assembly Modulator Canocapavir: A Randomized First-in-Human Study
2023
·
Xiuhong Jiang
, Bo Hua
, et al.
·
Gastro Hep Advances
·
6
Safety, tolerability, pharmacokinetics, and preliminary antiviral activity of the capsid assembly modulator (CAM) ZM-H1505R after multiple escalatiing oral dosed in patients with chronic hepatitis B virus (CHB) Infection
2022
·
Jiajia Mai
, Hong Zhang
, et al.
·
Journal of Hepatology
·
2
[Expert consensus on evaluation index system construction for new traditional Chinese medicine(TCM) from TCM clinical practice in medical institutions].
2025
·
Li Liu
, Lei Zhang
, et al.
·
PubMed
Electrophysiological and Pharmacological Characterization of a Novel and Potent Neuronal Kv7 Opener SCR2682 for Anti-Epilepsy
2019
·
Yani Liu
, Fan Zhang
, et al.
·
Biophysical Journal
PDF
Show more works
View as search
Works count:
7
Citation count:
85
Year
Topic
Type